Skip to content

Clinical trials

Atrial Fibrillation trials in the United Kingdom with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Not applicable Country / region: United Kingdom Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20072
20081
20095
20103
20113
20124
20137
20148
20154
20167
201710
20188
20195
20206
20218
202212
20236
202412
20255
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Unknown status21
Recruiting16
Active, not recruiting10
Terminated6
Withdrawn4
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Barts & The London NHS Trust15
Oxford University Hospitals NHS Trust9
Liverpool Heart and Chest Hospital NHS Foundation Trust8
Imperial College London7
Abbott Medical Devices6
Royal Brompton & Harefield NHS Foundation Trust6
Boston Scientific Corporation4
Medtronic Cardiac Rhythm and Heart Failure4
AtriCure, Inc.3
Biosense Webster, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation121
Arrhythmias, Cardiac14
Heart Failure13
Stroke6
Ischemic Stroke5
Cardiovascular Diseases4
Hemorrhage3
Heart Murmurs2
Obesity2
Overweight2

Trials

Showing 1 to 25 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.